Skip to Content
Cancer Imaging Program (CIP)
Contact CIP
Show menu
Search this site
Last Updated: 11/20/18

Reports & Publications

  • Young CR, Adler S, Eary JF, Lindenberg ML, Jacobs PM, Collins J, Kummar S, Kurdziel KA, Choyke PL, Mena E. Biodistribution, tumor detection and radiation dosimetry of F-18 5-Fluoro-2'-Deoxycytidine (18F-FdCyd) with Tetrahydrouridine in solid tumors. J Nucl Med. 2018 Nov 2.

  • McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH, Jacobs PM, Lenkinski RE, Maravilla KR, Prince MR, Rowley HA, Tweedle MF, Kressel HY. Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. Radiology. 2018 Nov;289(2):517-534.

  • Jaffray DA, Das S, Jacobs PM, Jeraj R, Lambin P. How Advances in Imaging Will Affect Precision Radiation Oncology. Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):292-298.

  • Harmon SA, Bergvall E, Mena E, Shih JH, Adler S, McKinney Y, Mehralivand S, Citrin DE, Couvillon A, Madan RA, Gulley JL, Mease RC, Jacobs PM, Pomper MG, Turkbey B, Choyke PL, Lindenberg ML. A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer. J Nucl Med. 2018 Nov;59(11):1665-1671.

  • Lindenberg L, Adler S, Turkbey IB, Mertan F, Ton A, Do K, Kummar S, Gonzalez EM, Bhattacharyya S, Jacobs PM, Choyke P. Dosimetry and first human experience with 89Zr-panitumumab. Am J Nucl Med Mol Imaging. 2017 Sep 1;7(4):195-203.

  • Shields AF, Jacobs PM, Sznol M, Graham MM, Germain RN, Lum LG, Jaffee EM, de Vries EGE, Nimmagadda S, Van den Abbeele AD, Leung DK, Wu AM, Sharon E, Shankar LK. Immune Modulation Therapy and Imaging: Workshop Report. J Nucl Med. 2018 Mar;59(3):410-417.

  • Turkbey B, Mena E, Lindenberg L, Adler S, Bednarova S, Berman R, Ton AT, McKinney Y, Eclarinal P, Hill C, Afari G, Bhattacharyya S, Mease RC, Merino MJ, Jacobs PM, Wood BJ, Pinto PA, Pomper MG, Choyke PL. 18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology. Clin Nucl Med. 2017 Oct;42(10):735-740.

  • Peterson LM, Kurland BF, Schubert EK, Link JM, Gadi VK, Specht JM, Eary JF, Porter P, Shankar LK, Mankoff DA, Linden HM. Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC). Mol Imaging Biol. 2018 Oct 15.

  • Beindorff N, Bartelheimer A, Huang K, Lukas M, Lange C, Huang EL, Aschenbach JR, Eary JF, Steffen IG, Brenner W. Normal Values of Thyroid Uptake of 99mTechnetium Pertechnetate SPECT in Mice with Respect to Age, Sex, and Circadian Rhythm. Nuklearmedizin. 2018 Sep;57(5):181-189.

  • Wolsztynski E, O'Sullivan F, Keyes E, O'Sullivan J, Eary JF. Positron emission tomography-based assessment of metabolic gradient and other prognostic features in sarcoma. J Med Imaging (Bellingham). 2018 Apr;5(2):024502.

  • Ehlerding EB, Grodzinski P, Cai W, Liu CH. Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. ACS Nano. 2018 Mar 27;12(3):2106-2121.

  • Hartshorn CM, Bradbury MS, Lanza GM, Nel AE, Rao J, Wang AZ, Wiesner UB, Yang L, Grodzinski P. Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care. ACS Nano. 2018 Jan 23;12(1):24-43.

  • Press RH, Shu HG, Shim H, Mountz JM, Kurland BF, Wahl RL, Jones EF, Hylton NM, Gerstner ER, Nordstrom RJ, Henderson L, Kurdziel KA, Vikram B, Jacobs MA, Holdhoff M, Taylor E, Jaffray DA, Schwartz LH, Mankoff DA, Kinahan PE, Linden HM, Lambin P, Dilling TJ, Rubin DL, Hadjiiski L, Buatti JM. The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1219-1235.

  • Press RH, Shu HG, Shim H, Mountz JM, Kurland BF, Wahl RL, Jones EF, Hylton NM, Gerstner ER, Nordstrom RJ, Henderson L, Kurdziel KA, Vikram B, Jacobs MA, Holdhoff M, Taylor E, Jaffray DA, Schwartz LH, Mankoff DA, Kinahan PE, Linden HM, Lambin P, Dilling TJ, Rubin DL, Hadjiiski L, Buatti JM. Fluorescence-guided surgery and intervention - An AAPM emerging technology blue paper. Med Phys. 2018 Jun;45(6):2681-2688.

  • Nordstrom RJ. Special Section Guest Editorial: Quantitative Imaging and the Pioneering Efforts of Laurence P. Clarke. J Med Imaging (Bellingham). 2018 Jan;5(1):011001. Peterson LM, Kurland BF, Schubert EK, Link JM, Gadi VK, Specht JM, Eary JF, Porter P, Shankar LK, Mankoff DA, Linden HM. Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC). Mol Imaging Biol. 2018 Oct 15.

  • Hristova I, Boellaard R, Galette P, Shankar LK, Liu Y, Stroobants S, Hoekstra OS, Oyen WJG. Guidelines for quality control of PET/CT scans in a multicenter clinical study. EJNMMI Phys. 2017 Sep 18;4(1):23.

  • Shields AF, Jacobs PM, Sznol M, Graham MM, Germain RN, Lum LG, Jaffee EM, de Vries EGE, Nimmagadda S, Van den Abbeele AD, Leung DK, Wu AM, Sharon E, Shankar LK. Immune Modulation Therapy and Imaging: Workshop Report. J Nucl Med. 2018 Mar;59(3):410-417.

  • Huang EP, Lin FI, Shankar LK. Beyond Correlations, Sensitivities, and Specificities: A Roadmap for Demonstrating Utility of Advanced Imaging in Oncology Treatment and Clinical Trial Design. Acad Radiol. 2017 Aug;24(8):1036-1049.

  • Lin FI, Huang EP, Shankar LK. Beyond Correlations, Sensitivities, and Specificities: Case Examples of the Evaluation of Advanced Imaging in Oncology Clinical Trials and Cancer Treatment. Acad Radiol. 2017 Aug;24(8):1027-1035.

  • Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litière S, Dancey J, Chen A, Hodi FS, Therasse P, Hoekstra OS, Shankar LK, Wolchok JD, Ballinger M, Caramella C, de Vries EG; RECIST working group. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017 Mar;18(3):e143-e152.

  • Scheuermann JS, Reddin JS, Opanowski A, Kinahan PE, Siegel BA, Shankar LK, Karp JS. Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials. J Nucl Med. 2017 Jul;58(7):1065-1071.

  • Crandall JP, Tahari AK, Juergens RA, Brahmer JR, Rudin CM, Esposito G, Subramaniam DS, Knopp MV, Hall NC, Gajwani P, Leal JP, Lodge MA, O JH, Gabrielson EW, Shankar LK, Wahl RL. A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC. EJNMMI Res. 2017 Dec;7(1):8.

  • Henderson LA, Shankar LK. Clinical Translation of the National Institutes of Health's Investments in Nanodrug Products and Devices. AAPS J. 2017 Mar;19(2):343-359.

  • O'Connor JP, Aboagye EO, Adams JE, Aerts HJ, Barrington SF, Beer AJ, Boellaard R, Bohndiek SE, Brady M, Brown G, Buckley DL, Chenevert TL, Clarke LP, Collette S, Cook GJ, deSouza NM, Dickson JC, Dive C, Evelhoch JL, Faivre-Finn C, Gallagher FA, Gilbert FJ, Gillies RJ, Goh V, Griffiths JR, Groves AM, Halligan S, Harris AL, Hawkes DJ, Hoekstra OS, Huang EP, Hutton BF, Jackson EF, Jayson GC, Jones A, Koh DM, Lacombe D, Lambin P, Lassau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lythgoe MF, Manoharan P, Maxwell RJ, Miles KA, Morgan B, Morris S, Ng T, Padhani AR, Parker GJ, Partridge M, Pathak AP, Peet AC, Punwani S, Reynolds AR, Robinson SP, Shankar LK, Sharma RA, Soloviev D, Stroobants S, Sullivan DC, Taylor SA, Tofts PS, Tozer GM, van Herk M, Walker-Samuel S, Wason J, Williams KJ, Workman P, Yankeelov TE, Brindle KM, McShane LM, Jackson A, Waterton JC. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017 Mar;14(3):169-186.

  • Airan, R.D., Foss, C.A., Ellens, N.P., Wang, Y., Mease, R.C., Farahani, K., and Pomper, M.G. (2017). MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused Ultrasound. Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 19, 24-30.

  • Armato, S.G., 3rd, Drukker, K., Li, F., Hadjiiski, L., Tourassi, G.D., Engelmann, R.M., Giger, M.L., Redmond, G., Farahani, K., Kirby, J.S., and Clarke, L.P. (2016). LUNGx Challenge for computerized lung nodule classification. Journal of medical imaging (Bellingham, Wash) 3, 044506.

  • Crandall, J.P., Tahari, A.K., Juergens, R.A., Brahmer, J.R., Rudin, C.M., Esposito, G., Subramaniam, D.S., Knopp, M.V., Hall, N.C., Gajwani, P., Leal, J.P., Lodge, M.A., O, J.H., Gabrielson, E.W., Shankar, L.K., and Wahl, R.L. (2017). A comparison of FLT to FDG PET/CT in the early assessment of chemotherapy response in stages IB-IIIA resectable NSCLC. EJNMMI research 7, 8.

  • Farahani, K. (2016a). MO-DE-202-01: Image-Guided Focused Ultrasound Surgery and Therapy. Medical physics 43, 3699-3700.

  • Farahani, K. (2016b). TU-FG-207B-00: Federal Funding Opportunities and Grantsmanship. Medical physics 43, 3763-3764.

  • Farahani, K. (2016c). TU-FG-207B-04: NCI Funding Opportunities in Imaging and Image-Guided Therapy. Medical physics 43, 3763-3764.

  • FitzGerald, T.J., Bishop-Jodoin, M., Followill, D.S., Galvin, J., Knopp, M.V., Michalski, J.M., Rosen, M.A., Bradley, J.D., Shankar, L.K., Laurie, F., Cicchetti, M.G., Moni, J., Coleman, C.N., Deye, J.A., Capala, J., and Vikram, B. (2016). Imaging and Data Acquisition in Clinical Trials for Radiation Therapy. International journal of radiation oncology, biology, physics 94, 404-411.

  • Henderson, L.A., and Shankar, L.K. (2016). Clinical Translation of the National Institutes of Health's Investments in Nanodrug Products and Devices. The AAPS journal.

  • Jacobs, P. (2016). TU-H-207B-02: Funding (NCI) for Radiomics. Medical physics 43, 3776.

  • Lin, F.I., Gonzalez, E.M., Kummar, S., Do, K., Shih, J., Adler, S., Kurdziel, K.A., Ton, A., Turkbey, B., Jacobs, P.M., Bhattacharyya, S., Chen, A.P., Collins, J.M., Doroshow, J.H., Choyke, P.L., and Lindenberg, M.L. (2016). Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy. European journal of nuclear medicine and molecular imaging.

  • Nordstrom, R.J. (2016). The Quantitative Imaging Network in Precision Medicine. Tomography : a journal for imaging research 2, 239-241.

  • O'Connor, J.P., Aboagye, E.O., Adams, J.E., Aerts, H.J., Barrington, S.F., Beer, A.J., Boellaard, R., Bohndiek, S.E., Brady, M., Brown, G., Buckley, D.L., Chenevert, T.L., Clarke, L.P., Collette, S., Cook, G.J., deSouza, N.M., Dickson, J.C., Dive, C., Evelhoch, J.L., Faivre-Finn, C., Gallagher, F.A., Gilbert, F.J., Gillies, R.J., Goh, V., Griffiths, J.R., Groves, A.M., Halligan, S., Harris, A.L., Hawkes, D.J., Hoekstra, O.S., Huang, E.P., Hutton, B.F., Jackson, E.F., Jayson, G.C., Jones, A., Koh, D.M., Lacombe, D., Lambin, P., Lassau, N., Leach, M.O., Lee, T.Y., Leen, E.L., Lewis, J.S., Liu, Y., Lythgoe, M.F., Manoharan, P., Maxwell, R.J., Miles, K.A., Morgan, B., Morris, S., Ng, T., Padhani, A.R., Parker, G.J., Partridge, M., Pathak, A.P., Peet, A.C., Punwani, S., Reynolds, A.R., Robinson, S.P., Shankar, L.K., Sharma, R.A., Soloviev, D., Stroobants, S., Sullivan, D.C., Taylor, S.A., Tofts, P.S., Tozer, G.M., van Herk, M., Walker-Samuel, S., Wason, J., Williams, K.J., Workman, P., Yankeelov, T.E., Brindle, K.M., McShane, L.M., Jackson, A., and Waterton, J.C. (2016). Imaging biomarker roadmap for cancer studies. Nature reviews Clinical oncology.

  • Pearlman, P.C., Divi, R., Gwede, M., Tandon, P., Sorg, B.S., Ossandon, M.R., Agrawal, L., Pai, V., Baker, H., and Lash, T.B. (2016). The National Institutes of Health Affordable Cancer Technologies Program: Improving Access to Resource-Appropriate Technologies for Cancer Detection, Diagnosis, Monitoring, and Treatment in Low- and Middle-Income Countries. IEEE journal of translational engineering in health and medicine 4, 2800708.

  • Rieves, D., and Jacobs, P. (2016). The Use of Published Clinical Study Reports to Support U.S. Food and Drug Administration Approval of Imaging Agents. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 57, 2022-2026.

  • Rosenthal, E.L., Warram, J.M., de Boer, E., Basilion, J.P., Biel, M.A., Bogyo, M., Bouvet, M., Brigman, B.E., Colson, Y.L., DeMeester, S.R., Gurtner, G.C., Ishizawa, T., Jacobs, P.M., Keereweer, S., Liao, J.C., Nguyen, Q.T., Olson, J.M., Paulsen, K.D., Rieves, D., Sumer, B.D., Tweedle, M.F., Vahrmeijer, A.L., Weichert, J.P., Wilson, B.C., Zenn, M.R., Zinn, K.R., and van Dam, G.M. (2016). Successful Translation of Fluorescence Navigation During Oncologic Surgery: A Consensus Report. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 57, 144-150.

  • Schwartz, L.H., Litiere, S., de Vries, E., Ford, R., Gwyther, S., Mandrekar, S., Shankar, L., Bogaerts, J., Chen, A., Dancey, J., Hayes, W., Hodi, F.S., Hoekstra, O.S., Huang, E.P., Lin, N., Liu, Y., Therasse, P., Wolchok, J.D., and Seymour, L. (2016). RECIST 1.1-Update and clarification: From the RECIST committee. European journal of cancer (Oxford, England : 1990) 62, 132-137.

  • Schwartz, L.H., Seymour, L., Litiere, S., Ford, R., Gwyther, S., Mandrekar, S., Shankar, L., Bogaerts, J., Chen, A., Dancey, J., Hayes, W., Hodi, F.S., Hoekstra, O.S., Huang, E.P., Lin, N., Liu, Y., Therasse, P., Wolchok, J.D., and de Vries, E. (2016). RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group. European journal of cancer (Oxford, England : 1990) 62, 138-145.

  • Singh, S., Rana, P., Kumar, P., Shankar, L.R., and Khushu, S. (2016). Hippocampal Neurometabolite Changes in Hypothyroidism: An In Vivo (1) H Magnetic Resonance Spectroscopy Study Before and After Thyroxine Treatment. Journal of neuroendocrinology 28.

  • Yankeelov, T.E., Mankoff, D.A., Schwartz, L.H., Lieberman, F.S., Buatti, J.M., Mountz, J.M., Erickson, B.J., Fennessy, F.M., Huang, W., Kalpathy-Cramer, J., Wahl, R.L., Linden, H.M., Kinahan, P.E., Zhao, B., Hylton, N.M., Gillies, R.J., Clarke, L., Nordstrom, R., and Rubin, D.L. (2016). Quantitative Imaging in Cancer Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 22, 284-290.